These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 23036826)
1. The interaction between dopamine transporter function, gender differences, and possible laterality in depression. Hsiao MC; Lin KJ; Liu CY; Schatz DB Psychiatry Res; 2013 Jan; 211(1):72-7. PubMed ID: 23036826 [TBL] [Abstract][Full Text] [Related]
2. Dopamine transporter availability in medication free and in bupropion treated depression: a 99mTc-TRODAT-1 SPECT study. Argyelán M; Szabó Z; Kanyó B; Tanács A; Kovács Z; Janka Z; Pávics L J Affect Disord; 2005 Dec; 89(1-3):115-23. PubMed ID: 16213028 [TBL] [Abstract][Full Text] [Related]
3. Bupropion occupancy of the dopamine transporter is low during clinical treatment. Meyer JH; Goulding VS; Wilson AA; Hussey D; Christensen BK; Houle S Psychopharmacology (Berl); 2002 Aug; 163(1):102-5. PubMed ID: 12185406 [TBL] [Abstract][Full Text] [Related]
4. A preliminary study of dopamine transporter binding in bipolar and unipolar depressed patients and healthy controls. Amsterdam JD; Newberg AB Neuropsychobiology; 2007; 55(3-4):167-70. PubMed ID: 17657170 [TBL] [Abstract][Full Text] [Related]
5. Greater availability of brain dopamine transporters in major depression shown by [99m Tc]TRODAT-1 SPECT imaging. Brunswick DJ; Amsterdam JD; Mozley PD; Newberg A Am J Psychiatry; 2003 Oct; 160(10):1836-41. PubMed ID: 14514499 [TBL] [Abstract][Full Text] [Related]
6. Dopamine transporter density may be associated with the depressed affect in healthy subjects. Newberg A; Amsterdam J; Shults J Nucl Med Commun; 2007 Jan; 28(1):3-6. PubMed ID: 17159542 [TBL] [Abstract][Full Text] [Related]
7. Greater striatal dopamine transporter density may be associated with major depressive episode. Amsterdam JD; Newberg AB; Soeller I; Shults J J Affect Disord; 2012 Dec; 141(2-3):425-31. PubMed ID: 22482744 [TBL] [Abstract][Full Text] [Related]
8. Changes of dopamine transporter availability in depressed patients with and without anhedonia: a 123I-N-ω-fluoropropyl-carbomethoxy-3β- (4-Iodophenyl)tropane SPECT study. Camardese G; De Risio L; Di Nicola M; Pucci L; Cocciolillo F; Bria P; Giordano A; Janiri L; Di Giuda D Neuropsychobiology; 2014; 70(4):235-43. PubMed ID: 25613182 [TBL] [Abstract][Full Text] [Related]
9. [Change of dopamine transporter activity (DAT) during the action of bupropion (in depression)]. Szabó Z; Argyelán M; Kanyó B; Pávics L; Janka Z Neuropsychopharmacol Hung; 2004 Jun; 6(2):79-81. PubMed ID: 15787205 [TBL] [Abstract][Full Text] [Related]
10. Bupropion and venlafaxine responders differ in pretreatment regional cerebral metabolism in unipolar depression. Little JT; Ketter TA; Kimbrell TA; Dunn RT; Benson BE; Willis MW; Luckenbaugh DA; Post RM Biol Psychiatry; 2005 Feb; 57(3):220-8. PubMed ID: 15691522 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of Tourette's syndrome by (99m)Tc-TRODAT-1 SPECT/CT imaging. Liu H; Dong F; Meng Z; Zhang B; Tan J; Wang Y Ann Nucl Med; 2010 Aug; 24(7):515-21. PubMed ID: 20544324 [TBL] [Abstract][Full Text] [Related]
12. Comparison of striatal dopamine transporter levels in chronic heroin-dependent and methamphetamine-dependent subjects. Yuan J; Liu XD; Han M; Lv RB; Wang YK; Zhang GM; Li Y Addict Biol; 2017 Jan; 22(1):229-234. PubMed ID: 26040446 [TBL] [Abstract][Full Text] [Related]
13. Bupropion Causes Misdiagnosis in Brain Dopamine Transporter Imaging for Parkinsonism. Honkanen EA; Kemppainen N; Noponen T; Seppänen M; Joutsa J; Kaasinen V Clin Neuropharmacol; 2019; 42(5):181-183. PubMed ID: 31361666 [TBL] [Abstract][Full Text] [Related]
14. Dopamine transporter binding in social anxiety disorder: the effect of treatment with escitalopram. Warwick JM; Carey PD; Cassimjee N; Lochner C; Hemmings S; Moolman-Smook H; Beetge E; Dupont P; Stein DJ Metab Brain Dis; 2012 Jun; 27(2):151-8. PubMed ID: 22350963 [TBL] [Abstract][Full Text] [Related]
16. Methylphenidate DAT binding in adolescents with Attention-Deficit/ Hyperactivity Disorder comorbid with Substance Use Disorder--a single photon emission computed tomography with [Tc(99m)]TRODAT-1 study. Szobot CM; Shih MC; Schaefer T; Júnior N; Hoexter MQ; Fu YK; Pechansky F; Bressan RA; Rohde LA Neuroimage; 2008 Apr; 40(3):1195-201. PubMed ID: 18282769 [TBL] [Abstract][Full Text] [Related]
17. No changes in striatal dopamine transporter in antidepressant-treated patients with major depression. Wu CK; Chin Chen K; See Chen P; Chiu NT; Yeh TL; Lee IH; Yang YK Int Clin Psychopharmacol; 2013 May; 28(3):141-4. PubMed ID: 23524636 [TBL] [Abstract][Full Text] [Related]
19. Reproducibility of brain dopamine transporter binding with Tc-99m TRODAT-1 SPECT in healthy young men. Yeh CB; Chou YH; Cheng CY; Lee MS; Wang JJ; Lee CH; Shiue CY; Su TP; Huang WS Psychiatry Res; 2012 Mar; 201(3):222-5. PubMed ID: 22551783 [TBL] [Abstract][Full Text] [Related]
20. Distribution volume ratio of serotonin and dopamine transporters in euthymic patients with a history of major depression - a dual-isotope SPECT study. Hsieh PC; Lee IH; Yeh TL; Chen KC; Huang HC; Chen PS; Yang YK; Yao WJ; Lu RB; Chiu NT Psychiatry Res; 2010 Dec; 184(3):157-61. PubMed ID: 21030217 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]